Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

EPA Finalizes Hazardous Waste Pharmaceuticals Rule

By Karlie Webb & Greg Blount on December 12, 2018
Email this postTweet this postLike this postShare this post on LinkedIn

Today U.S. EPA finalized new hazardous waste regulations in its final Management Standards for Hazardous Waste Pharmaceuticals rule.  In brief, the rule creates a new Subpart P to 40 Code of Federal Regulations Part 266, which is specific to hazardous waste pharmaceuticals.  The rule applies to all “healthcare facilities” (such as hospitals and retail pharmacies) and “reverse distributors.”   The rule requires that all healthcare facilities and reverse distributors manage hazardous waste pharmaceuticals in accordance with the new subpart P regulations.  We are carefully reviewing the final rule and implications to clients, as well as implications to state hazardous waste requirements.

The final rule should be published in the Federal Register in the coming weeks, and the final rule will become effective at the federal level six months after publication in the Federal Register.

Join Troutman Sanders and Georgia State Law in Atlanta on February 6, 2019 for a symposium regarding consumer products in the environment, which will include a discussion with U.S. EPA on the new rule.  You may view additional detail and register using this link.

Photo of Karlie Webb Karlie Webb

Karlie assists clients in all areas of environmental compliance for existing operations and environmental due diligence for real estate and equity transactions. Clients turn to Karlie when they are acquiring a property or company, and then rely on her environmental compliance counsel post-acquisition.

Read more about Karlie WebbEmail
Photo of Greg Blount Greg Blount
Email
  • Posted in:
    Environmental and Climate
  • Blog:
    Environmental Law & Policy Monitor
  • Organization:
    Troutman Pepper Locke
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo